Rutin could improve lipid accumulation in the liver and alleviate lipid metabolism dysfunction in diabetic NAFLD through the AMPK/SREBP1 pathway [27]. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.